Armstrong Fleming & Moore’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $590K | Buy |
756
+501
| +196% | +$391K | 0.32% | 51 |
|
|
2025
Q1 | $211K | Sell |
255
-501
| -66% | -$414K | 0.26% | 75 |
|
|
2024
Q4 | $584K | Hold |
756
| – | – | 0.35% | 45 |
|
|
2024
Q3 | $670K | Sell |
756
-74
| -9% | -$65.6K | 0.39% | 44 |
|
|
2024
Q2 | $752K | Buy |
830
+13
| +2% | +$11.8K | 0.48% | 40 |
|
|
2024
Q1 | $636K | Buy |
817
+57
| +8% | +$44.4K | 0.44% | 42 |
|
|
2023
Q4 | $443K | Hold |
760
| – | – | 0.33% | 60 |
|
|
2023
Q3 | $408K | Hold |
760
| – | – | 0.4% | 56 |
|
|
2023
Q2 | $357K | Buy |
+760
| New | +$357K | 0.33% | 61 |
|